- Home
- VCTR vs VKTX Comparison
VCTR vs VKTX Comparison
Compare VCTR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCTR
- VKTX
- Stock Information
- Founded
- VCTR 2013
- VKTX 2012
- Country
- VCTR United States
- VKTX United States
- Employees
- VCTR N/A
- VKTX N/A
- Industry
- VCTR Investment Managers
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- VCTR Finance
- VKTX Health Care
- Exchange
- VCTR Nasdaq
- VKTX Nasdaq
- Market Cap
- VCTR 4.0B
- VKTX 3.4B
- IPO Year
- VCTR 2018
- VKTX 2015
- Fundamental
- Price
- VCTR $56.28
- VKTX $23.94
- Analyst Decision
- VCTR Buy
- VKTX Strong Buy
- Analyst Count
- VCTR 9
- VKTX 12
- Target Price
- VCTR $69.67
- VKTX $89.75
- AVG Volume (30 Days)
- VCTR 340.9K
- VKTX 4.5M
- Earning Date
- VCTR 05-08-2025
- VKTX 04-23-2025
- Dividend Yield
- VCTR 3.00%
- VKTX N/A
- EPS Growth
- VCTR 40.38
- VKTX N/A
- EPS
- VCTR 4.38
- VKTX N/A
- Revenue
- VCTR $893,477,000.00
- VKTX N/A
- Revenue This Year
- VCTR $38.45
- VKTX N/A
- Revenue Next Year
- VCTR $14.15
- VKTX N/A
- P/E Ratio
- VCTR $12.85
- VKTX N/A
- Revenue Growth
- VCTR 8.82
- VKTX N/A
- 52 Week Low
- VCTR $42.10
- VKTX $18.92
- 52 Week High
- VCTR $73.42
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- VCTR 47.22
- VKTX 46.06
- Support Level
- VCTR $55.16
- VKTX $18.92
- Resistance Level
- VCTR $58.04
- VKTX $27.09
- Average True Range (ATR)
- VCTR 3.47
- VKTX 2.31
- MACD
- VCTR 0.27
- VKTX 0.26
- Stochastic Oscillator
- VCTR 66.55
- VKTX 61.44
About VCTR Victory Capital Holdings Inc.
Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.